Navigation Links
Data from Multiple Clinical Trials of OrbusNeich's Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT 2010
Date:9/25/2010

nduces less neointimal hyperplasia than bare metal stents," said Professor Wojakowski.  "These data confirm that Genous is safe and effective in patients with ACS with no stent thrombosis."

Genous Bio-engineered R stent shows complete endothelialization in majority of patients at 30 days post-implantation.

Dr. Pasi Karjalainen, M.D., Ph.D., of the Satakunta Central Hospital in Pori, Finland, presented 30-day follow-up optical coherence tomography (OCT) evaluations from 13 patients treated with the Genous Bio-engineered Cobalt Chromium Stent. The findings showed:

  • Out of 2224 stent struts, 96 percent analyzed were completely covered at 30 days.

  • The Doppler assessment of coronary flow velocity (CFR) demonstrated a functional endothelium at 30 days in almost all patients.

Dr. Karjalainen commented, "The complete endothelialization at 30 days in patients treated with the Genous stent demonstrates the ability of the EPC capture technology to accelerate the body's natural healing process."

Al Novak, Chairman and CEO of OrbusNeich, added, "The extensive clinical data sets presented today further support the use of the Genous Bio-engineered R stent as a safe and effective treatment option in challenging cases."

The symposium, which was chaired by Professor Dr. Sigmund Silber, M.D., Ph.D., of the Kardiologische Klinik Dr Muller, Munich, also featured a presentation about OrbusNeich's next generation Combo™ Bio-engineered Sirolimus Eluting Stent (Combo Stent). Professor Michael Haude, M.D., of Medical Clinic I at the Lukaskrankenhaus in Neuss, Germany, presented "The Future in DES: Combo."

About Genous  

Genous is OrbusNeich's patented endothelial progenitor cell (EPC) capture technology that promotes the accelerated natural healing of the vessel wall after the implantation of blood-contact devi
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
7. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
8. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
9. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013  BioElectronics Corporation (OTC Pink: BIEL), the ... on the FDA panel meeting for non-thermal shortwave diathermy: ... Pulsed Shortwave Therapy Meeting was held on May 21, ... The focus of the meeting was very narrow, in ... solely on the application of non-thermal shortwave diathermy for ...
(Date:5/23/2013)... , May 23, 2013  Intercept Pharmaceuticals, Inc. (Nasdaq: ... company focused on the development and commercialization of novel ... as primary biliary cirrhosis, today announced that ... Officer, will present at the Deutsche Bank Securities 38th ... on Wednesday, May 29, 2013 at 4:10 p.m. ...
(Date:5/23/2013)...  Inhibikase Therapeutics, Inc., an emerging leader in ... present new results on its antiviral program to ... the PML Consortium (composed of Pfizer, Bristol-Meyers Squibb, ... the causative agent of Progressive Multifocal Leukoencephalopathy (PML). ... extended release formulation, can clear JC polyomavirus (JCV) ...
Breaking Medicine Technology:BioElectronics and Pulsed Shortwave Therapy Make Progress 2Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2
... Oct. 7 Nile Therapeutics, Inc. (Nasdaq: ... of novel therapeutics for cardiovascular disease, today announced that ... Advisory Board overseeing the development of CD-NP, a dual ... of acute decompensated heart failure. Dr. ...
... Reportlinker.com announces that a new market research report ... RIS/PACS Market http://www.reportlinker.com/p0306627/European-RIS/PACS-Market.html ... terms of the challenges faced by market participants, drivers ... the research service include an executive summary, overview of ...
Cached Medicine Technology:Michael R. Bristow, M.D. Ph.D. Joins Nile Therapeutics Scientific Advisory Board 2Michael R. Bristow, M.D. Ph.D. Joins Nile Therapeutics Scientific Advisory Board 3Reportlinker Adds European RIS/PACS Market 2Reportlinker Adds European RIS/PACS Market 3
(Date:5/23/2013)... Maintaining its commitment to improving life ... Campaign. Kicking off in the spirit of Better Sleep ... for everyone and to providing a therapeutic sleep experience, ... May is Better Sleep Month, a result of the ... due to the Centers for Disease Control’s confirmation that ...
(Date:5/23/2013)... To kick off barbecue season, fire up the grill this ... with simple tips from Retrofit weight loss . Keep ... , “The powerful heat of the grill can be one ... not mindful of your selections, it can be as bad ... Margulies. , Margulies advises clients to choose healthy options from ...
(Date:5/23/2013)... May 23, 2013 Retül University ... proud to announce the formation of a strategic educational ... Technologies to offer a bike industry first “Positioned ... aerodynamic assessment for time trial, road and triathlon bike ... offered to bike fitters with a Retül University, F.I.S.T. ...
(Date:5/23/2013)... to moderate iodine deficiency during pregnancy may have a ... report. Low levels of the so-called "trace element" ... child at risk of poorer verbal and reading skills ... women can boost their iodine levels by eating enough ... finding, published online May 22 in The Lancet ...
(Date:5/23/2013)... of support for war influences soldier PTSD , ... heightened risk for developing post-traumatic stress disorder if public ... recent research. Social validation or invalidation shapes the level ... the researchers say. The study involved two experiments that ... grinder in one, having an actor show either ...
Breaking Medicine News(10 mins):Health News:DUXIANA®, Quality Bed Innovator, Celebrates Better Sleep Month and Launches Summer Health Campaign 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 3Health News:Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course 2Health News:Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course 3Health News:Low Prenatal Iodine May Affect Child's Brain Development 2Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 2Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 3
... could expose people to serious risks of injury and even death ... ,As lung cancer is the leading cause of cancer deaths among ... could save lives. But a study in New York seems to ... ,Dr. Peter B. Bach, a lung specialist and epidemiologist, who ...
... the number of amyloid plaques in the brains of ... like Alzheimer's. ,Roderic Eckenhoff, MD, Vice Chair ... Anesthesia and Critical Care, and his co-authors, report their ... of Aging. ,Every year over 100 million ...
... grow a genetically modified (GM) variety of rice from ... company behind the proposal, Ventria Bioscience, says the plants ... in infants. ,These plants, incorporating human genes ... some 3,000 acres (1,215 hectares) of farmland in the ...
... intake of soy isoflavones significantly reduced the risk of prostate ... cent//, says a new study. ,"To our knowledge, ... association between isoflavone and localized prostate cancer in Japanese, whose ... Kurahashi from Japan's National Cancer Center. ,Over half ...
... food industry representatives in Sydney has come out with the ... The move follows similar ones followed overseas by other food ... under pressure from the federal government to deal with the ... of trans fats in foods ,to be spelled out on ...
... faster than the current laboratory based detection, which may ... ,Sheila MacNeil and researchers at Sheffield University have ... bacteria in less then a minute by using light, ... ,The technology could have wide applications in wound healing, ...
Cached Medicine News:Health News:CT Scans may Not Benefit Lung Cancer Patients 2Health News:Inhaled Anesthetics Accelerate the Onset of Neurodegenerative Diseases Like Alzheimer's 2Health News:Soy Isoflavones Linked to Lower Prostate Cancer Risk 2
... are constructed of a patented ... polyvinyl acetal sponge. Each device ... to both surgeon and patient, ... firm enough to gently manipulate ...
... KeraCel Ophthalmic Products are constructed ... of lint-free MEROCEL polyvinyl acetal ... to be beneficial to both ... absorbent, and yet firm enough ...
... Ophthalmic Products provide the ... free products for unparalleled ... cleaning of fine microsurgical ... material is highly absorbent, ...
... Merocel Ophthalmic Products provide ... fiber free products for ... safe cleaning of fine ... Merocel material is highly ...
Medicine Products: